95 related articles for article (PubMed ID: 8678696)
1. [The action of intravenous flecainide in experimental ventricular arrhythmias].
de Micheli A; Medrano GA; Casanova JM
Arch Inst Cardiol Mex; 1995; 65(5):403-12. PubMed ID: 8678696
[TBL] [Abstract][Full Text] [Related]
2. [Effect of intravenous verapamil in experimental ventricular arrhythmia].
de Micheli A; Medrano GA; Casanova JM
Arch Inst Cardiol Mex; 1995; 65(6):484-95. PubMed ID: 8948683
[TBL] [Abstract][Full Text] [Related]
3. Effects of verapamil in ventricular tachycardias. An experimental and clinical study.
De Micheli A; Medrano GA; Iturralde P; Casanova JM
Acta Cardiol; 1997; 52(1):1-15. PubMed ID: 9139517
[TBL] [Abstract][Full Text] [Related]
4. [Response of experimental ventricular tachycardia to class I anti-arrhythmia agents].
de Micheli A; Medrano GA
Arch Inst Cardiol Mex; 1992; 62(1):11-24. PubMed ID: 1562206
[TBL] [Abstract][Full Text] [Related]
5. [Early and late effects of adenosine in experimental ventricular tachycardia].
de Micheli A; Chávez Domínguez R; Iturralde Torres P; Pastelín G; Medrano GA
Rev Esp Cardiol; 2005 Feb; 58(2):159-66. PubMed ID: 15743562
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic and arrhythmogenic action of inosine in experimental ventricular tachyarrhythmias.
de Micheli A; Pastelín G; Chávez Domínguez R; Iturralde Torres P; Medrano GA
Arch Cardiol Mex; 2009; 79(3):175-81. PubMed ID: 19902663
[TBL] [Abstract][Full Text] [Related]
7. Reversal of flecainide-induced ventricular arrhythmia by hypertonic sodium bicarbonate in dogs.
Salerno DM; Murakami MM; Johnston RB; Keyler DE; Pentel PR
Am J Emerg Med; 1995 May; 13(3):285-93. PubMed ID: 7755819
[TBL] [Abstract][Full Text] [Related]
8. [Intravenous flecainide administration for conversion of paroxysmal atrial fibrillation in the emergency room].
Antonelli D; Feldman A; Freedberg NA; Darawsha A; Rosenfeld T
Harefuah; 2006 May; 145(5):342-4, 398. PubMed ID: 16805213
[TBL] [Abstract][Full Text] [Related]
9. Arrhythmogenic effect of flecainide toxicity.
Courand PY; Sibellas F; Ranc S; Mullier A; Kirkorian G; Bonnefoy E
Cardiol J; 2013; 20(2):203-5. PubMed ID: 23558880
[TBL] [Abstract][Full Text] [Related]
10. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
11. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
Kidwell GA; Greenspon AJ; Greenberg RM; Volosin KJ
Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998
[TBL] [Abstract][Full Text] [Related]
12. Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome.
Pellizzón OA; Kalaizich L; Ptácek LJ; Tristani-Firouzi M; Gonzalez MD
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):95-7. PubMed ID: 17655675
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
Amino M; Yoshioka K; Iwata O; Fujikura H; Deguchi Y; Ban K; Shiina Y; Goto S; Handa S; Tanabe T; Nakagawa Y; Morita S; Iwase H; Yamamoto I; Inokuchi S; Marutani Y
J Cardiol; 2003 Mar; 41(3):127-34. PubMed ID: 12674997
[TBL] [Abstract][Full Text] [Related]
14. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
[TBL] [Abstract][Full Text] [Related]
15. Successful use of an intravenous infusion of flecainide and amiodarone for a refractory combination of postoperative junctional and ectopic tachycardias.
Haas NA; Fox S; Skinner JR
Cardiol Young; 2005 Aug; 15(4):427-30. PubMed ID: 16014194
[TBL] [Abstract][Full Text] [Related]
16. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
[TBL] [Abstract][Full Text] [Related]
17. Determinants and mechanisms of flecainide-induced promotion of ventricular tachycardia in anesthetized dogs.
Ranger S; Nattel S
Circulation; 1995 Sep; 92(5):1300-11. PubMed ID: 7648679
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic and cardioprotective effects of remifentanil in anesthetized dogs.
Luna-Ortiz P; Zarco-Olvera G; Ramírez-Ortega M; Tenorio-López FA; Gutiérrez A; Martínez-Rosas M; Del-Valle Mondragón L; Pastelín G
Arch Cardiol Mex; 2009; 79(3):182-8. PubMed ID: 19902664
[TBL] [Abstract][Full Text] [Related]
19. Effects of flecainide on atrial and ventricular refractoriness in rabbits in vitro and in vivo.
Leung MW; Chan AP; So PP; Lowe GC; Guppy LJ; Walker MJ
Proc West Pharmacol Soc; 2004; 47():42-5. PubMed ID: 15633609
[TBL] [Abstract][Full Text] [Related]
20. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
